AllianceBernstein
IMGN

AllianceBernstein’s Immunogen Inc IMGN Stock Holding History

AllianceBernstein’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,507,809
Closed -$44.7M – 3211
2023
Q4 		$44.7M Buy
1,507,809
+1,207,295
+402% +$24M 0.02% 620
2023
Q3 		$4.77M Hold
300,514
– – ﹤0.01% 1450
2023
Q2 		$5.67M Buy
300,514
+11,850
+4% +$140K ﹤0.01% 1383
2023
Q1 		$1.11M Hold
288,664
– – ﹤0.01% 2180
2022
Q4 		$1.43M Sell
288,664
-35,409
-11% -$192K ﹤0.01% 2097
2022
Q3 		$1.55M Sell
324,073
-156,248
-33% -$824K ﹤0.01% 2049
2022
Q2 		$2.16M Buy
480,321
+191,657
+66% +$833K ﹤0.01% 1911
2022
Q1 		$1.37M Buy
288,664
+800
+0.3% +$4.43K ﹤0.01% 2303
2021
Q4 		$2.14M Sell
287,864
-126,607
-31% -$787K ﹤0.01% 2105
2021
Q3 		$2.35M Buy
414,471
+126,607
+44% +$732K ﹤0.01% 2072
2021
Q2 		$1.9M Hold
287,864
– – ﹤0.01% 2227
2021
Q1 		$2.33M Hold
287,864
– – ﹤0.01% 1998
2020
Q4 		$1.86M Hold
287,864
– – ﹤0.01% 2032
2020
Q3 		$1.04M Sell
287,864
-9,700
-3% -$39.2K ﹤0.01% 2169
2020
Q2 		$1.37M Buy
297,564
+6,600
+2% +$28.1K ﹤0.01% 2047
2020
Q1 		$992K Hold
290,964
– – ﹤0.01% 2040
2019
Q4 		$1.49M Sell
290,964
-27,700
-9% -$94K ﹤0.01% 2108
2019
Q3 		$771K Sell
318,664
-11,600
-4% -$30.8K ﹤0.01% 2364
2019
Q2 		$717K Buy
330,264
+108,600
+49% +$257K ﹤0.01% 2457
2019
Q1 		$601K Sell
221,664
-115,780
-34% -$502K ﹤0.01% 2454
2018
Q4 		$1.62M Buy
337,444
+122,241
+57% +$742K ﹤0.01% 1952
2018
Q3 		$2.04M Sell
215,203
-314
-0.1% -$3.02K ﹤0.01% 1925
2018
Q2 		$2.1M Buy
215,517
+95,353
+79% +$1.01M ﹤0.01% 1879
2018
Q1 		$1.26M Sell
120,164
-600
-0.5% -$5.93K ﹤0.01% 2118
2017
Q4 		$774K Buy
120,764
+2,500
+2% +$15.4K ﹤0.01% 2407
2017
Q3 		$905K Hold
118,264
– – ﹤0.01% 2324
2017
Q2 		$841K Hold
118,264
– – ﹤0.01% 2377
2017
Q1 		$458K Sell
118,264
-34,700
-23% -$101K ﹤0.01% 2569
2016
Q4 		$312K Hold
152,964
– – ﹤0.01% 2728
2016
Q3 		$410K Sell
152,964
-28,900
-16% -$84K ﹤0.01% 2598
2016
Q2 		$560K Buy
181,864
+35,900
+25% +$225K ﹤0.01% 2477
2016
Q1 		$1.24M Sell
145,964
-280
-0.2% -$2.37K ﹤0.01% 1958
2015
Q4 		$1.99M Sell
146,244
-12,304
-8% -$151K ﹤0.01% 1625
2015
Q3 		$1.52M Sell
158,548
-17,186
-10% -$251K ﹤0.01% 1885
2015
Q2 		$2.53M Buy
175,734
+11,000
+7% +$121K ﹤0.01% 1602
2015
Q1 		$1.47M Hold
164,734
– – ﹤0.01% 1950
2014
Q4 		$1M Sell
164,734
-2,706
-2% -$24.7K ﹤0.01% 2202
2014
Q3 		$1.77M Hold
167,440
– – ﹤0.01% 1812
2014
Q2 		$1.98M Sell
167,440
-11
-0% -$138 ﹤0.01% 1777
2014
Q1 		$2.5M Sell
167,451
-33
-0% -$520 ﹤0.01% 1540
2013
Q4 		$2.46M Sell
167,484
-6,422
-4% -$98.7K ﹤0.01% 1563
2013
Q3 		$2.96M Sell
173,906
-8,328
-5% -$146K ﹤0.01% 1401
2013
Q2 		$3.02M Buy
+182,234
New +$2.95M ﹤0.01% 1324

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AllianceBernstein's IMGN Position: Q1 2024 in Review

AllianceBernstein sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,507,809 shares — an estimated $44.7M sold.

AllianceBernstein first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $44.7M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • AllianceBernstein reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • AllianceBernstein sold 1,507,809 Immunogen Inc shares in Q1 2024, an estimated $44.7M.
  • AllianceBernstein first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • AllianceBernstein's Immunogen Inc position peaked at $44.7M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.